FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like Genentech's Lymphoma Drug Combo Wows in Mid-Stage Trial December 10, 2017 Cancer Biotech G1 Therapeutics Grabs $105 Million in IPO May 16, 2017 4 Biotechs That Could Release Stock-Shattering Data Soon May 9, 2017
